Civic Intelligence

Partnership for Expanded Access and Compassionate Hope

990EZ • Fiscal year 2020 • EIN 47-2394724

Jul 01, 2019 to Jun 30, 2020

Portland, OR
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

55th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2020

Net Margin

Score unavailable

No value available

Net margin requires both revenue and expenses on this filing.

Source year 2020

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2020

Asset Growth

41st percentile

-0.2%

Faster asset growth than 41% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Revenue Growth

Score unavailable

No value available

A valid growth rate could not be computed from the available filing history.

Annualized from 2019 to 2020

Assets

Down

$197,943

Down $356 (-0.2%) from 2019

Net Assets

-

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

Flat

$0

Flat from 2019

Expenses

Up

$356

Up $46 (+15%) from 2019

Net Income

Down

-$356

Down $46 (-15%) from 2019

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$200K$150K$100K$50K$0Assets 2015: $1Liabilities 2015: $02015Assets 2016: $199,929Liabilities 2016: $0Net Assets 2016: $199,9292016Assets 2017: $199,119Net Assets 2017: $199,1192017Assets 2018: $198,609Net Assets 2018: $198,6092018Assets 2019: $198,299Net Assets 2019: $198,2992019Assets 2020: $197,943Liabilities 2020: $02020Assets 2021: $197,633Net Assets 2021: $197,6332021Assets 2022: $197,318Net Assets 2022: $197,3182022Assets 2023: $146,973Liabilities 2023: $02023Assets 2024: $146,373Liabilities 2024: $02024Assets 2025: $146,973Net Assets 2025: $146,9732025

Highlighted filing

2020

Assets$197,943
Liabilities$0
Net Assets-

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$200K$100K$0-$100KRevenue 2015: $0Expenses 2015: $0Net Income 2015: $02015Revenue 2016: $200,000Expenses 2016: $71Net Income 2016: $199,9292016Revenue 2017: $0Expenses 2017: $810Net Income 2017: -$8102017Revenue 2018: $0Expenses 2018: $510Net Income 2018: -$5102018Revenue 2019: $0Expenses 2019: $310Net Income 2019: -$3102019Revenue 2020: $0Expenses 2020: $356Net Income 2020: -$3562020Revenue 2021: $0Expenses 2021: $310Net Income 2021: -$3102021Revenue 2022: $0Expenses 2022: $315Net Income 2022: -$3152022Revenue 2023: $0Expenses 2023: $50,345Net Income 2023: -$50,3452023Revenue 2024: $0Expenses 2024: $600Net Income 2024: -$6002024Revenue 2025: $6002025

Highlighted filing

2020

Revenue$0
Expenses$356
Net Income-$356
Filing Detail Status

This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jul 1, 2019 to Jun 30, 2020
Mission and Program Overview

Mission

To facilitate access of cancer patients to therapeutic agents that are not yet approved for their disease.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings